MorphoSys AG ADR buy Stakeholder
Start price
05.08.20
/
50%
€29.00
Target price
04.11.21
-
Performance (%)
-62.07%
End price
17.08.21
€11.00
Summary
This prediction ended on 17.08.21 with a price of €11.00. The BUY prediction by Stakeholder for MorphoSys AG ADR performed very badly with a performance of -62.07%. Stakeholder has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
MorphoSys AG ADR | - | - | - | - |
iShares Core DAX® | 1.280% | 1.320% | 13.605% | 15.782% |
iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% | 38.434% |
iShares Nikkei 225® | -2.006% | -1.389% | 8.973% | 6.570% |
iShares S&P 500 | -0.662% | -1.884% | 23.684% | 39.611% |
Comments by Stakeholder for this prediction
In the thread Morphosys AG diskutieren
Zulassung des Krebsmedikamentes Monjuvi in den USA